Utilization of Xpert MTB/RIF molecular test and Thorax Radiography as Tuberculosis Screening at PKU Muhammadiyah Bantul Hospital
Keywords:
Thorax radiology; XPERT MTB/RIF molecular test; Rapid diagnosis,; TuberculosisAbstract
Tuberculosis is a disease caused by the bacteria Mycobacterium tuberculosis, and approximately 25% of the global population is afflicted with this bacterium. In 2022,The objective of this study is to assess the effectiveness of the Xpert MTB/RIF Molecular Test and Thorax Radiography as diagnostic tools for tuberculosis at PKU Muhammadiyah Bantul Hospital. The research employed quantitative methodologies with a cross-sectional design. The majority of tuberculosis suspects at PKU Muhammadiyah Bantul Hospital were individuals aged 64 years or older, based on age group. In terms of gender, 498 individuals were male. According to the Xpert MTB/RIF molecular test, 89 individuals tested positive for tuberculosis. In contrast, the number of individuals who tested positive for tuberculosis through thorax photo examination was 184. The findings indicate that the majority of patients suspected of having Tuberculosis were males and were primarily in the age category of above 64 years old. Thorax photo radiography yielded a higher number of confirmed positive tuberculosis findings compared to the Xpert MTB/RIF molecular test, based on the evaluation of individuals suspected of having tuberculosis.
References
World Health Organization. Tuberculosis. https://www.who.int/health-topics/tuberculosis#tab=tab_1
Patterson B, Wood R. Is cough really necessary for TB transmission? Tuberculosis (Edinb). 2019;117:31-35. doi:10.1016/j.tube.2019.05.003
Gralton J, Tovey E, McLaws M-L, Rawlinson WD. The role of particle size in aerosolised pathogen transmission: a review. J Infect. 2011;62(1):1-13.
Loudon RG, Roberts RM. Singing and the dissemination of tuberculosis. Am Rev Respir Dis. 1968;98(2):297-300.
WHO. World Health Organization South-East Asia Indonesia: TB Day 2022.
Villar-Hernández R, Ghodousi A, Konstantynovska O, Duarte R, Lange C, Raviglione M. Tuberculosis: current challenges and beyond. Breathe (Sheffield, England). 2023;19(1):220166. doi:10.1183/20734735.0166-2022
Kemenkes RI. Profil Kesehatan Indonesia 2020.; 2021.
Kemenkes RI. Profil Kesehatan Indonesia 2022.; 2023.
Dinkes Kabupaten Bantul. Profil Kesehatan Kabupaten Bantul 2022.; 2023.
Dinkes Kabupaten Bantul. Profil Kesehatan Bantul 2021. Dinkes Kabupaten Bantul; 2022.
Laily DW, Rombot D V., Lampus BS. Karakteristik pasien Tuberkulosis Paru di Puskesmas Tuminting Manado. J Kedokt Komnitas dan Trop. 2015;3(1):1-5.
Lestari NPWA, Dedy MAE, Artawan IM, Buntoro IF. Perbedaan Usia Dan Jenis Kelamin Terhadap Ketuntasan Pengobatan Tb Paru Di Puskesmas Di Kota Kupang. Cendana Med J. 2022;10(1):24-31.
Sunarmi S, Kurniawaty K. Hubungan Karakteristik Pasien Tb Paru Dengan Kejadian Tuberkulosis. J ’Aisyiyah Med. 2022;7(2):182-187. doi:10.36729/jam.v7i2.865
Kemenkes RI. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis.; 2020.
Moree T, Lawrence H. Crash Course Kedokteran Respirasi. 1st ed. (Isbaniah F, ed.). Elsevier Singapore Pte Ltd; 2022.
Majdawati A. Uji Diagnostik Gambaan Lesi Foto Thorax pada Penderita dengan Klinis Tuberkulosis Paru. Mutiara Med. 2010;10(2):180-188.
Utami PR, Amelia N, Susanto V, Adfar TD. Pemeriksaan GeneXpert Terhadap Tingkat Positivitas Pemeriksaan Basil Tahan Asam (BTA) Metode Ziehl Neelsen Pada Penderita Suspek TB Paru. J Kesehat Perintis. 2021;8(1):82-90.
Chairani C, Utami PR, Indrayati S, Almurdi A, Rahmayana R. Perbedaan Hasil Pemeriksaan Mikroskopis BTA Pada Pasien TB Paru Sebelum dan Sesudah Pengobatan Fixed-Dose Combination (FDC) Fase Intensif. J Kesehat Perintis. 2023;10(1):68-73.
Zhu M, Han G, Takiff HE, et al. Times series analysis of age-specific tuberculosis at a rapid developing region in China, 2011-2016. Sci Rep. 2018;8(1):8727. doi:10.1038/s41598-018-27024-w
Andayani S. Prediksi Kejadian Penyakit Tuberkulosis Paru Berdasarkan Jenis Kelamin. J Keperawatan Muhammadiyah Bengkulu. 2020;8(2):135-140.
Hartiyah L, Rahmiati R, Dwi Santoyo D. Gambaran Hasil Pemeriksaan Tes Cepat Molekuler Mycobacterium Tuberculosis Di Rsud Ulin Banjarmasin Tahun 2020-2021. Homeostasis. 2023;6(1):69-76. doi:10.20527/ht.v6i1.8791
Sava C, Sava M, Drăgan A-M, et al. The Use of Xpert MTB/RIF Ultra Testing for Early Diagnosis of Tuberculosis: A Retrospective Study from a Single-Center Database. Genes (Basel). 2023;14(6). doi:10.3390/genes14061231
Kemenkes RI. Petunjuk Teknis Pemeriksaan TB Menggunakan Tes Cepat Molekuler.; 2017.
Tamtyas FI, Rini CS. The Detection of TB Lungs with Microscopic and the Rapid Molecular Test Methods. Medicra (Journal Med Lab Sci. 2020;3(1):1-4. doi:10.21070/medicra.v3i1.650
Wita A, Fransiska E. Hubungan Kv Terhadap Ketebalan Objek Ayu Wita Sari. J Heal. Published online 2018:17-21.
Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013;13(4):349-361. doi:10.1016/S1473-3099(13)70008-2
Bomanji JB, Gupta N, Gulati P, Das CJ. Imaging in tuberculosis. Cold Spring Harb Perspect Med. 2015;5(6). doi:10.1101/cshperspect.a017814
Bhalla AS, Goyal A, Guleria R, Gupta AK. Chest tuberculosis: Radiological review and imaging recommendations. Indian J Radiol Imaging. 2015;25(3):213-225. doi:10.4103/0971-3026.161431
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Elvina Prisila, Novi Wijayanti Sukirto, Nurcholid Umam, Ana Budi Rahayu, Dewi Yuniasih, Ardyawati Wira Oktaviana, Febrianti Putri Nurulita
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
License and Copyright Agreement
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal. Please also carefully read Ahmad Dahlan Medical Journal posting Your Article Policy.
- That it is not under consideration for publication elsewhere.
- That its publication has been approved by all the author(s) and by the responsible authorities - tacitly or explicitly - of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
Copyright
Authors who publish with Ahmad Dahlan Medical Journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
